Tell us about new Phyto medical approaches towards diabetes

New phytomedical approaches to diabetes are gaining attention as plant-based compounds show promising glucose-lowering, antioxidant, and insulin-sensitizing effects. Bioactive extracts from plants such as Moringa oleifera, Vernonia amygdalina, and Azadirachta indica are being studied for their potential to improve glycemic control and reduce complications. Advances in phytochemistry and nanotechnology are also enhancing the efficacy and delivery of these natural therapies. As interest grows, questions remain around standardization, safety, and clinical validation. What are your thoughts on integrating phytomedicine into mainstream diabetes care, and what research gaps should we prioritize?